Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2024; 70(5): 108-120


Helicobacter pylori and its Role in the Pathogenesis of Diseases of the Digestive System

I.V. Kolosovych

  1. Bogomolets National Medical University, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz70.05.108


Abstract

Helicobacter pylori is a gram-negative bacterium that is quite common among the world’s population. To date, the pathogenetic mechanisms of the bacterium’s influence on gastroduodenal ulcers and gastric cancer have been most deeply studied. However, there is a growing number of sources devoted to the association of Helicobacter pylori with the occurrence of many extra-gastric diseases. These data are quite contradictory and controversial. Given the close anatomical and functional relationship of the digestive system (digestive tract and digestive glands), it is quite natural that the bacterium Helicobacter pylori, which persists in the antrum of the stomach, has a pathological effect on this system, causing the development of a number of diseases and their complications. The purpose of this study is to analyze the current state of the problem of the role of Helicobacter pylori in the pathogenesis of diseases of the digestive system. This review presents the latest data on the pathogenetic mechanisms of gastroduodenal ulcer and gastric cancer. The persistence of the bacterium in the pancreatic-biliary system causes cholecystitis, and gallstone disease, including cholelithiasis, acute and chronic pancreatic inflammation, non-alcoholic fatty liver disease, and liver cirrhosis. Various mechanisms of carcinogenesis of tumors of the liver, gallbladder and bile ducts, and pancreas, in which Helicobacter pylori is directly involved, are highlighted. Further study of the role of the bacterium as a predictor of the development of diseases of the digestive system and their complications is promising and relevant

Keywords: Helicobacter pylori, digestive system diseases, liver, gallbladder, pancreas, stomach

References

  1. FitzGerald R, Smith SM. An overview of helicobacter pylori infection. Method Mol Biol. 2021; 2283:1-14. CrossRef PubMed
  2. de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019 Oct 7;25(37):5578-89. CrossRef PubMed PubMedCentral
  3. Sun Y, Zhang J. Helicobacter pylori recrudescence and its influencing factors. J Cell Mol Med. 2019 Dec;23(12):7919-25. CrossRef PubMed PubMedCentral
  4. Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019 Mar 21;380(12):1158-65. CrossRef PubMed
  5. Ali A, AlHussaini KI. Helicobacter pylori: A contemporary perspective on pathogenesis, diagnosis and treatment strategies. Microorganisms. 2024 Jan 22;12(1):222. CrossRef PubMed PubMedCentral
  6. Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol. 2019 Sep 7;25(33):4870-84. CrossRef PubMed PubMedCentral
  7. Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019 Nov 19;11(11):677. CrossRef PubMed PubMedCentral
  8. Oparin SO, Korotkyï VM, Kolosovych IV, Spitsyn RIu, Furmanenko MF, Kartashov BT, Martynovych LD, Krasovs'kyĭ VO, Butyrin SO, Zinchenko II, Rupitsev OO, Dzhurko MG. Operative treatment of complicated duodenal and pyloric ulcer disease. Klin Khir. 2000 Nov;(11):20-2. [Ukrainian].
  9. Wang M, Kong WJ, Zhang JZ, Lu JJ, Hui WJ, Liu WD, Kang XJ, Gao F. Association of Helicobacter pylori infection with colorectal polyps and malignancy in China. World J Gastrointest Oncol. 2020 May 15;12(5):582-91. CrossRef PubMed PubMedCentral
  10. Yang S, Xia YP, Luo XY, Chen SL, Li BW, Ye ZM, Chen SC, Mao L, Jin HJ, Li YN, Hu B. Exosomal CagA derived from Helicobacter pylori-infected gastric epithelial cells induces macrophage foam cell formation and promotes atherosclerosis. J Mol Cell Cardiol. 2019 Oct;135:40-51. CrossRef PubMed
  11. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018 Aug 7;24(29):3204-21. CrossRef PubMed PubMedCentral
  12. Crowe SE. Helicobacter pylori Infection. N Engl J Med. 2019 Mar 21;380(12):1158-65. CrossRef PubMed
  13. Aydın EM, Demir TD, Seymen N, Said SS, Oktem-Okullu S, Tiftikci A, Cicek B, Tokat F, Tozun N, Ince U, Sezerman U, Sayi-Yazgan A. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Immunol Lett. 2021 Nov;239:1-11. CrossRef PubMed
  14. Chmiela M, Kupcinskas J. Review: Pathogenesis of helicobacter pylori infection. Helicobacter. 2019 Sep;24 Suppl 1:e12638. CrossRef PubMed PubMedCentral
  15. Helicobacter pylori infection. Nat Rev Dis Primers. 2023 Apr 20;9(1):20. CrossRef
  16. Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019 Sep;24 Suppl 1:e12635. CrossRef PubMed
  17. Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023 Apr 20;9(1):19. CrossRef PubMed PubMedCentral
  18. Xie J, Liu D, Peng J, Wu S, Liu D, Xie Y. Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert Rev Anti Infect Ther. 2023 Apr;21(4):447-54. CrossRef PubMed
  19. Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019 Nov 19;11(11):677. CrossRef PubMed PubMedCentral
  20. Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022 Mar;53(1):33-50. CrossRef PubMed PubMedCentral
  21. Mathews J, Malik P, Rai A, Lin J, Kim RS, Pan DH. A single centre experience of treatment outcomes for Helicobacter pylori infection among inner-city children and adolescents. Acta Paediatr. 2020 Sep;109(9):1860-6. CrossRef PubMed
  22. Cessa-Zanatta JC, García-Compeán D, MaldonadoGarza HJ, Borjas-Almaguer OD, Jiménez-Rodríguez AR, Del Cueto-Aguilera ÁN, González-González JA. Helicobacter pylori infection is associated with decreased odds for eosinophilic esophagitis in Mexican patients. Gastroenterol Hepatol. 2024 Feb;47(2):149-57. English, Spanish. CrossRef
  23. Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory helicobacter pylori infection: Expert Rev Gastroenterol. 2021 Apr;160(5):1831-41. CrossRef PubMed PubMedCentral
  24. Abdelfattah T, Shahab O, Shah TU. Gastric intestinal metaplasia: when to treat? How to treat? Curr Opin Gastroenterol. 2021 Nov 1;37(6):602-8. CrossRef PubMed
  25. Kolosovych IV, Bezrodnyĭ BH, Chemodanov PV, Sysak OM. Surgical tactics at "difficult" perforative duodenal ulcers. Lik Sprava. 2013 Sep;(6):60-8. [Ukrainian]. CrossRef
  26. Zhang X, Arnold IC, Müller A. Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori. Curr Opin Microbiol. 2020 Apr;54:1-10. CrossRef PubMed
  27. Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020 Dec 25;10(1):27. CrossRef PubMed PubMedCentral
  28. Uberti AF, Callai-Silva N, Grahl MVC, Piovesan AR, Nachtigall EG, Furini CRG, Carlini CR. Helicobacter pylori urease: Potential contributions to Alzheimer's disease. Int J Mol Sci. 2022 Mar 13;23(6):3091. CrossRef PubMed PubMedCentral
  29. Korotkyĭ VM, Kolosovych IV. Pharmacotherapeutic aspects of early postoperative period in patients with complicated gastroduodenal ulcer. Klin Khir. 2002 Feb;(2):15-8. [Ukrainian].
  30. Yaratha K, Talemal L, Monahan BV, Yu D, Lu X, Poggio JL. Seasonal and Geographic Variation in Peptic Ulcer Disease and Associated Complications in the United States of America. J Res Health Sci. 2023 Dec 29;23(4):e00595. CrossRef PubMed PubMedCentral
  31. Javanbakhat P, Peeridogaheh H, Nemati R, Yazdanbod A, Teimourpour A, Sadeghnezhad M, Esmaelizad M, Teimourpour R. Exploring virulence factors of Helicobacter pylori isolated from gastric biopsy. Mol Biol Rep. 2024 Jan 25;51(1):192. CrossRef PubMed
  32. Haghighat S, Blandon C, Goldberg D, Kumar S. Association between country of birth and gastric intestinal metaplasia: a retrospective cohort study. Lancet Reg Health Am. 2023 Nov 28;28:100635. CrossRef PubMed PubMedCentral
  33. Li N, Xu X, Zhan Y, Fei X, Ouyang Y, Zheng P, Zhou Y, He C, Xie C, Hu Y, Hong J, Lu N, Ge Z, Zhu Y. YAP and β-catenin cooperate to drive H. pylori-induced gastric tumorigenesis. Gut Microbes. 2023 JanDec;15(1):2192501. CrossRef PubMed PubMedCentral
  34. Muzaheed. Helicobacter pylori oncogenicity: Mechanism, prevention, and risk factors. Sci World J. 2020 Jul 12;2020:3018326. CrossRef PubMed PubMedCentral
  35. Cheng M, Zheng Y, Fan Y, Yan P, Zhao W. The contribution of IL-17A-dependent low LCN2 levels to Helicobacter pylori infection: Insights from clinical and experimental studies. Int Immunopharmacol. 2023 Nov;124(Pt B):110960. CrossRef PubMed
  36. Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, Joo J. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020 Jan 30;382(5):427-36. CrossRef PubMed
  37. Wang L, Wang H. The putative role of ferroptosis in gastric cancer: a review. Eur J Cancer Prev. 2023 Nov 1;32(6):575-83. CrossRef PubMed PubMedCentral
  38. Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Upper gastrointestinal cancer and liver cirrhosis. Cancers (Basel). 2022 May 2;14(9):2269. CrossRef PubMed PubMedCentral
  39. Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol. 2020 Jul 28;26(28):4076-93. CrossRef PubMed PubMedCentral
  40. Wang L, Chen J, Jiang W, Cen L, Pan J, Yu C, Li Y, Chen W, Chen C, Shen Z. The relationship between Helicobacter pylori infection of the gallbladder and chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2021 Jan 6;2021:8886085. CrossRef PubMed PubMedCentral
  41. Lim KPK, Lee AJL, Jiang X, Teng TZJ, Shelat VG. The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: A review. Ann Hepatobiliary Pancreat Surg. 2023 Aug 31;27(3):241-50. CrossRef PubMed PubMedCentral
  42. Azimirad M, Sadeghi A, Hosseinkhan N, Mirbagheri SZ, Alebouyeh M. Microbiome analysis of bile samples in patients with choledocholithiasis and hepatobiliary disorders. Germs. 2023 Sep 30;13(3):238-53. CrossRef PubMed PubMedCentral
  43. Sulo P, Šipková B. DNA diagnostics for reliable and universal identification of Helicobacter pylori. World J Gastroenterol. 2021 Nov 7;27(41):7100-12. CrossRef PubMed PubMedCentral
  44. Osaki T, Lin Y, Sasahira N, Ueno M, Yonezawa H, Hojo F, Okuda M, Matsuyama M, Sasaki T, Kobayashi S, Tezuka S, Tanaka K, Dan N, Kuruma S, Egawa N, Kamiya S, Kikuchi S. Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers. Helicobacter. 2022 Feb;27(1):e12866. CrossRef PubMed PubMedCentral
  45. Cherif S, Rais H, Hakmaoui A, Sellami S, Elantri S, Amine A. Linking Helicobacter pylori with gallbladder and biliary tract cancer in Moroccan population using clinical and pathological profiles. Bioinformation. 2019 Oct 31;15(10):735-43. CrossRef PubMed PubMedCentral
  46. Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021 Jan 30;397(10272):428-44. CrossRef PubMed
  47. Dangtakot R, Intuyod K, Chamgramol Y, Pairojkul C, Pinlaor S, Jantawong C, Pongking T, Haonon O, Ma N, Pinlaor P. CagA+ Helicobacter pylori infection and N-nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters. Helicobacter. 2021 Aug;26(4):e12817. CrossRef PubMed
  48. Chai X, Wang J, Li H, Gao C, Li S, Wei C, Huang J, Tian Y, Yuan J, Lu J, Gao D, Zheng Y, Huang C, Zhou J, Shi G, Ke A, Liu F, Fan J, Cai J. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microb. 2023 Jan-Dec;15(1):2156255. CrossRef PubMed PubMedCentral
  49. Fadieienko G. D., Gridnyev O. Y., Gridnieva S. V. Nonalcoholic fatty liver disease and Helicobacter pylori infection: is there a relationship? Modern Gastroenterol. 2024 Feb; 1(135): 60-5. CrossRef
  50. Doulberis M, Srivastava S, Polyzos SA, Kountouras J, Papaefthymiou A, Klukowska-Rötzler J, Blank A, Exadaktylos AK, Srivastava DS. Active Helicobacter pylori infection is independently associated with nonalcoholic steatohepatitis in morbidly obese patients. J Clin Med. 2020 Mar 30;9(4):933. CrossRef PubMed PubMedCentral
  51. Feysa S.V. Lipid peroxidation and antioxidant defense status in patients with non-alcoholic fatty liver disease and concomitant hypothyroidism. Fiziol Zh. 2019;65(2):89-96. CrossRef
  52. Wei L, Ding HG. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine (Baltimore). 2021 Aug 6;100(31):e26706. CrossRef PubMed PubMedCentral
  53. Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The missing link between helicobacter pylori infection and metabolic disorders? Front Endocrinol (Lausanne). 2021 Jun 17;12:639856. CrossRef PubMed PubMedCentral
  54. van Nieuwkerk CM, Kuipers EJ. Liver cirrhosis and peptic ulcer disease; a correlation with Helicobacter pylori? Neth J Med. 2000 Jun;56(6):203-5. CrossRef PubMed
  55. Koyanagi YN, Suzuki E, Imoto I, Kasugai Y, Oze I, Ugai T, Iwase M, Usui Y, Kawakatsu Y, Sawabe M, Hirayama Y, Tanaka T, Abe T, Ito S, Komori K, Hanai N, Tajika M, Shimizu Y, Niwa Y, Ito H, Matsuo K. Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: An evaluation by mediation analysis. Cancer Res. 2020 Apr 1;80(7):1601-10. CrossRef PubMed
  56. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-49. CrossRef PubMed
  57. Nakane T, Fukunaga S, Nakano D, Tsutsumi T, Tanaka H, Chou T, Minami S, Ohuchi A, Nagata T, Takaki K, Takaki H, Miyajima I, Nouno R, Yoshinaga S, Mukasa M, Okabe Y, Kawaguchi T. Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer. Hepatol Res. 2023 Dec 29. CrossRef PubMed
  58. Salazar J, Le A. The heterogeneity of liver cancer metabolism. Adv Exp Med Biol. 2021;1311:127-36. . CrossRef PubMed PubMedCentral
  59. Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021 Jun;54(3):359-69. CrossRef PubMed
  60. Kolosovych IV, Hanol IV. Metabolic disorders caused by acute pancreatitis and ways of their correction using enteral nutrition of patients. Fiziol Zh. 2023; 69(4):92- CrossRef
  61. [Ukrainian].
  62. Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: A review. JAMA. 2021 Jan 26;325(4):382-90. CrossRef PubMed
  63. Kolosovych IV, Hanol IV. Purulent septic complications of acute pancreatitis and their pathogenetic relationship with Нelicobacter pylori. Novosti Khirurg. 2021 OctNov; (5): 542-8. CrossRef
  64. Synelnyk TB, Kravchenko OO, Kostiuk OS, Savchuk OM, Sukhodolia SA, Ostapchenko LI. Distribution of serine proteases in blood plasma and pancreas in chronic pancreatitis and oncopathology. Fiziol Zh. 2022;68(6):31-43. CrossRef
  65. Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020 Aug 15;396 (10249):499-512. CrossRef PubMed
  66. Gardner TB. Acute Pancreatitis. Ann Int Med. 2021 Feb;174(2):ITC17-ITC32. CrossRef PubMed
  67. Kunovsky L, Dite P, Jabandziev P, Dolina J, Vaculova J, Blaho M, Bojkova M, Dvorackova J, Uvirova M, Kala Z, Trna J. Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis. World J Gastrointest Oncol. 2021 Aug 15;13(8):835-44. CrossRef PubMed PubMedCentral
  68. Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Author correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A populationbased cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2020 Jul 28;10(1):12950. CrossRef PubMed PubMedCentral
  69. Zhou BG, Mei YZ, Wang JS, Xia JL, Jiang X, Ju SY, Ding YB. Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies. Ther Adv Chronic Dis. 2023 Feb 13;14:20406223231155119. CrossRef PubMed PubMedCentral
  70. Permuth JB, Rahman S, Chen DT, Waterboer T, Giuliano AR. A Case control study of the seroprevalence of Helicobacter pylori proteins and their Association with Pancreatic Cancer Risk. J Pancreat Cancer. 2021 Sep 16;7(1):57-64. CrossRef PubMed PubMedCentral
  71. Xu W, Zhou X, Yin M, Gao J, Weng Z, Xu C. The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis. Transl Cancer Res. 2022 Aug;11(8):2810-22. CrossRef PubMed PubMedCentral
  72. Kumar S, Metz DC, Kaplan DE, Goldberg DS. The association of Helicobacter pylori with pancreatic cancer. GastroHep. 2020 Jul;2(4):157-164. CrossRef PubMed PubMedCentral
  73. Gong Y, Chen S, Fu Y, Liu Y, Wang Y, Yang H, Liu H, Tang L. MUC4 is a novel mediator in H. pylori infection-related pancreatic cancer. Oncol Lett. 2021 Feb;21(2):123. CrossRef PubMed PubMedCentral
  74. Li P, Shu Y, Gu Y. The potential role of bacteria in pancreatic cancer: a systematic review. Carcinogenesis. 2020 Jun 17;41(4):397-404. CrossRef PubMed
  75. Panthangi V, Cyril Kurupp AR, Raju A, Luthra G, Shahbaz M, Almatooq H, Foucambert P, Esbrand FD, Zafar S, Khan S. Association between Helicobacter pylori infection and the risk of pancreatic cancer: A systematic review based on observational studies. Cureus. 2022 Aug 29;14(8):e28543. CrossRef
  76. Chen Y, Wu G, Zhao Y. Gut microbiota and alimentary tract injury. Adv Exp Med Biol. 2020;1238:11-22. CrossRef PubMed
  77. Chen J, Ma J, Liu X, Duan S, Liang N, Yao S. The association between Helicobacter pylori infection with overweight/obesity: A protocol for a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2020 Jan;99(3):e18703. CrossRef PubMed PubMedCentral

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.